GIANNOTTA, JURI ALESSANDRO
GIANNOTTA, JURI ALESSANDRO
Universita' degli Studi di MILANO
A case of lymphadenopathies with concomitant multiple acquired hemostasis disorders in an adult female patient
2024 A. Truma, A. Artoni, J.A. Giannotta, M. Caronni, F. Peyvandi
Efficacy and safety of cyclosporine A treatment in autoimmune cytopenias: the experience of two Italian reference centers
2022 B. Fattizzo, S. Cantoni, J.A. Giannotta, L. Bandiera, R. Zavaglia, M. Bortolotti, W. Barcellini
Clinical exome sequencing for diagnosing severe cryptogenic liver disease in adults: A case series
2022 S. Pelusi, L. Ronzoni, F. Malvestiti, C. Bianco, I. Marini, R. D'Ambrosio, J.A. Giannotta, G. Soardo, M. Maggioni, D. Prati, L. Valenti
Low-Risk Myelodysplastic Syndrome Revisited: Morphological, Autoimmune, and Molecular Features as Predictors of Outcome in a Single Center Experience
2022 B. Fattizzo, G.V. Levati, J.A. Giannotta, G. Cassanello, L.M. Cro, A. Zaninoni, M. Barbieri, G.A. Croci, N. Revelli, W. Barcellini
Are Patients With Autoimmune Cytopenias at Higher Risk of COVID-19 Pneumonia? The Experience of a Reference Center in Northern Italy and Review of the Literature
2021 W. Barcellini, J.A. Giannotta, B. Fattizzo
Large Granular Lymphocyte Expansion in Myeloid Diseases and Bone Marrow Failure Syndromes : Whoever Seeks Finds
2021 B. Fattizzo, V. Bellani, R. Pasquale, J.A. Giannotta, W. Barcellini
Switching to an alternative recombinant erythropoietin agent in patients with myelodysplastic syndromes : a second honeymoon?
2021 B. Fattizzo, L. Rizzo, J.A. Giannotta, F. Mazzon, N. Cecchi, C. Frangi, W. Barcellini, M. Riva
Mitapivat sulfate
2021 W. Barcellini, J.A. Giannotta, N. Cecchi, B. Fattizzo
Difficult cases of paroxysmal nocturnal hemoglobinuria: Diagnosis and therapeutic novelties
2021 B. Fattizzo, F. Serpenti, J.A. Giannotta, W. Barcellini
Secondary hemophagocytic lymphohistiocytosis and autoimmune cytopenias: Case description and review of the literature
2021 B. Fattizzo, M. Ferraresi, J.A. Giannotta, W. Barcellini
A case of severe aplastic anaemia after SARS-CoV-2 vaccination
2021 N. Cecchi, J.A. Giannotta, W. Barcellini, B. Fattizzo
Off-Label Use of Thrombopoietin Receptor Agonists: Case Series and Review of the Literature
2021 M. Capecchi, F. Serpenti, J. Giannotta, L. Pettine, G. Reda, I. Martinelli, A. Artoni, W. Barcellini, B. Fattizzo
Bortezomib in autoimmune hemolytic anemia and beyond
2021 R. Pasquale, J.A. Giannotta, W. Barcellini, B. Fattizzo
Autoimmune complications in hematologic neoplasms
2021 W. Barcellini, J.A. Giannotta, B. Fattizzo
SARS-CoV-2 vaccination in patients with autoimmune cytopenias: The experience of a reference center
2021 B. Fattizzo, J.A. Giannotta, N. Cecchi, W. Barcellini
SARS-CoV-2 vaccination induces breakthrough hemolysis in paroxysmal nocturnal hemoglobinuria on complement inhibitor
2021 B. Fattizzo, J.A. Giannotta, N. Cecchi, W. Barcellini
Confounding factors in the diagnosis and clinical course of rare congenital hemolytic anemias
2021 B. Fattizzo, J.A. Giannotta, N. Cecchi, W. Barcellini
The Immunomodulatory Effect and Clinical Efficacy of Daratumumab in a Patient With Cold Agglutinin Disease
2021 A. Zaninoni, J.A. Giannotta, A. Galli, R. Artuso, P. Bianchi, L. Malcovati, W. Barcellini, B. Fattizzo
Infectious complications in autoimmune hemolytic anemia
2021 J.A. Giannotta, B. Fattizzo, F. Cavallaro, W. Barcellini
Circulating extracellular vesicles and cytokines in congenital and acquired hemolytic anemias
2021 W. Barcellini, A. Zaninoni, J.A. Giannotta, G. Merati, M. Capecchi, B. Fattizzo, E. Trombetta, A. Artoni